Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
| 10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | 10/31/2010 | |
|---|---|---|---|---|---|
| Revenue | 302.60K | 302.80K | 283.10K | 257.20K | 288.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 302.60K | 302.80K | 283.10K | 257.20K | 288.80K |
| Cost of Revenue | 16.20K | 49.70K | 49.40K | 48.30K | 46.10K |
| Gross Profit | 286.40K | 253.20K | 233.80K | 209.00K | 242.80K |
| SG&A Expenses | 306.10K | 229.50K | 203.90K | 196.00K | 186.80K |
| Depreciation & Amortization | 8.30K | 11.90K | 20.90K | 26.40K | 27.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 503.70K | 480.50K | 493.30K | 511.00K | 526.20K |
| Operating Income | -201.10K | -177.60K | -210.10K | -253.70K | -237.30K |
| Income Before Tax | -201.90K | -494.90K | -528.40K | -572.20K | -557.10K |
| Income Tax Expenses | -14.20K | -14.80K | -16.00K | -17.00K | -19.20K |
| Earnings from Continuing Operations | -0.19 | -0.48 | -0.51 | -0.56 | -0.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -187.80K | -480.20K | -512.50K | -555.20K | -537.90K |
| EBIT | -201.10K | -177.60K | -210.10K | -253.70K | -237.30K |
| EBITDA | -192.70K | -165.70K | -189.20K | -227.10K | -209.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.19B | 2.19B | 2.19B | 2.19B | 2.19B |
| Average Diluted Shares Outstanding | 2.19B | 2.19B | 2.19B | 2.19B | 2.19B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
